Calendar Alterity Therapeutics Limited

Equities

ATH

AU0000043945

Delayed Australian S.E. 03:15:37 30/04/2024 BST 5-day change 1st Jan Change
0.0055 AUD -8.33% Intraday chart for Alterity Therapeutics Limited -8.33% -21.43%

Chart calendar Alterity Therapeutics Limited

e0579afcd99bce6372.MWOkPcvN3pFzKhTXrKt_FyV2kXkA1rJyh7I7BwfZGgk.fVOWSJyUutlefl2_msoXLxYV_zJkicURxPBfdleadF8FBOhR_oWn-hBiZw~e9aab8efbc6ddba5c3570d4e222df153

Upcoming events on Alterity Therapeutics Limited

26/02/2025 Q2 2025 Earnings Release (Projected)
25/02/2026 Q2 2026 Earnings Release (Projected)
03/03/2027 Q2 2027 Earnings Release (Projected)

Past events on Alterity Therapeutics Limited

16/04/2024 18:45 American Academy of Neurology Meeting
16/04/2024 00:30 American Academy of Neurology Meeting
14/04/2024 18:45 American Academy of Neurology Meeting
11/04/2024 Extraordinary Shareholders Meeting
28/02/2024 05:07 Q2 2024 Earnings Release
02/02/2024 01:30 ShareCafe Hidden Gems Conference
28/12/2023 23:00 Extraordinary Shareholders Meeting
05/12/2023 22:00 Primates ATH434 Efficacy Data Results Call
29/11/2023 Future of Parkinson Disease Conference
28/11/2023 22:00 Annual General Meeting
29/10/2023 23:14 September 2023 Sales and Revenue Release - Activities Report
28/08/2023 12:00 Parkinson Disease and Movement Disorders International Congress - Abstract Number:181
28/08/2023 12:00 Parkinson Disease and Movement Disorders International Congress - Abstract Number:162
22/06/2023 01:30 MST Access Rare Diseases Rich ReturnsForum
22/05/2023 16:00 Shareholder Access and Retail Engagement Conference - Fireside Chat
27/04/2023 05:29 March 2023 Sales and Revenue Release - Activities Report
10/03/2023 01:30 ShareCafe Hidden Gems Presentation
28/02/2023 02:18 Q2 2023 Earnings Release
31/01/2023 12:25 December 2022 Sales and Revenue Release - Activities Report
10/11/2022 Annual General Meeting

Annual results

Fiscal PeriodJune 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


3,29
2,77
18.68%
3,53
3,50
0.76%
2,55
3,09
-17.31%

1,87

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-10,8
-11,0
2.43%
-10,4
-10,9
4.49%
-9,32
-11,1
15.99%

-8,69

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-11,2
-11,9
5.69%
-8,79
-10,3
14.99%
-8,90
-11,0
19.32%

-8,84

Net income
Million USD
Released
Forecast
Spread
-7,39


-11,2
-11,9
5.69%
-8,84
-10,3
14.53%
-8,97
-11,0
18.71%

-8,84

EPS
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Announcement Date30/08/2031/08/2131/08/2231/08/23-

Quarterly results

Fiscal PeriodJune 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million USD
Released
Forecast
Spread



1,88
1,39
35.26%



1,90
2,87
-33.69%
1,62
1,82
-11.14%



1,31
0,96
37.11%

0,91

EBIT
Million USD
Released
Forecast
Spread



-5,24
-5,61
6.7%



-5,19
-5,62
7.73%
-5,55
-5,10
-8.72%
-3,98
-5,65
29.53%
-4,17
-4,24
1.79%

-4,45

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-4,93
-5,73
13.95%



-4,26
-5,77
26.08%
-5,35
-5,21
-2.77%



-4,23
-4,32
2.06%

-4,52

Net income
Million USD
Released
Forecast
Spread
-6,81


-4,93
-5,73
13.95%
-4,78


-4,31
-5,77
25.24%
-5,42
-5,21
-4.12%



-4,23
-4,32
2.06%

-4,52

Announcement Date25/02/2131/08/2128/02/2231/08/2228/02/2331/08/2329/02/24-

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

  1. Stock Market
  2. Equities
  3. ATH Stock
  4. Calendar Alterity Therapeutics Limited